Live tape
Top 8, mentions 7d8,858GOOGL1,691 mentions▲ +0.04MRNA1,354 mentions▲ +0.09SNDK1,285 mentions▲ +0.11META1,126 mentions▲ +0.03NVDA1,045 mentions▲ +0.08SPCX899 mentions▲ +0.08NBIS744 mentions▲ +0.09MSFT714 mentions▲ +0.05

Equity · Healthcare

RCUS

Arcus Biosciences, Inc. · NYSE

$27.38 +1.41% 1D Finazon · prior-day close
Price · Chart

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for RCUS to draw a line in its place.

Track this symbol on TradingView

The chart above plots the price of RCUS over the range selected — one day to the full history — drawn by TradingView from their own data.

Market cap $3.5B
52-week range $9 – $31.01
Avg volume 273.6K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 18, 2026

RCUS insider trades

SEC Form 4

RCUS has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 10 July 2026.

Date Insider Type Shares Value
10 Jul 2026 Jaen Juan C. President Sell 20,067 $574K
09 Jul 2026 Jaen Juan C. President Sell 48,502 $1.46M
24 Jun 2026 Jaen Juan C. President Sell 6,431 $191K
23 Jun 2026 Jaen Juan C. President Sell 15,764 $437K
22 Jun 2026 Jaen Juan C. President Sell 9,236 $250K
01 Jun 2026 Azoy Alexander Chief Accounting Officer Sell 2,562 $66K
11 May 2026 Goeltz II Robert C. Chief Financial Officer Sell 7,763 $199K
05 Jan 2026 Jaen Juan C. President Sell 31,823 $681K
31 Dec 2025 Goeltz II Robert C. Chief Financial Officer Sell 6,552 $153K
18 Dec 2025 Azoy Alexander Chief Accounting Officer Sell 4,343 $97K
17 Dec 2025 ROSEN TERRY J Chief Executive Officer Sell 25,744 $570K
17 Dec 2025 Jaen Juan C. President Sell 9,983 $221K

Showing the 12 most recent of 38 open-market trades in this window. The figures above count all of them.

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
11 Jun 2026 PERLMAN ANDREW J Director Award 5,700
11 Jun 2026 FALBERG KATHRYN E Director Award 5,700
11 Jun 2026 KANEKO YASUNORI Director Award 5,700
11 Jun 2026 Machado Patrick Director Award 5,700
11 Jun 2026 Lacey David L. Director Award 5,700
11 Jun 2026 Lambert Nicole Director Award 5,700
11 Jun 2026 Ribas Antoni Director Award 5,700
11 Jun 2026 Tang Carolyn C. General Counsel Option exercise 34,090 $88K
23 Jan 2026 ROSEN TERRY J Chief Executive Officer Award 79,000
23 Jan 2026 Jaen Juan C. President Award 31,000
23 Jan 2026 Goeltz II Robert C. Chief Financial Officer Award 24,000
23 Jan 2026 Jarrett Jennifer Chief Operating Officer Award 31,000

Showing the 12 most recent of 22 compensation filings in this window. The figures above count all of them.

RCUS reported financials

SEC EDGAR XBRL

RCUS reported revenue of $33.0M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$353.0M.

Figure Reported Period
Revenue $33.0M 31 Dec 2025 fiscal year
Net income −$353.0M 31 Dec 2025 fiscal year
Diluted EPS −$3.29 31 Dec 2025 fiscal year
Total assets $924.0M 30 Jun 2026 at period end
Total equity $464.0M 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

RCUS earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $-0.72 $41M
31 Mar 2026 Q1 2026 $-1.02 $17M
31 Dec 2025 FY 2025 $-3.29 $247M
30 Sep 2025 Q3 2025 $-1.27 $26M
30 Jun 2025 Q2 2025 $0.00 $160M
31 Mar 2025 Q1 2025 $-1.14 $28M
31 Dec 2024 FY 2024 $-3.14 $258M
30 Sep 2024 Q3 2024 $-1.00 $48M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

RCUS institutional holders

SEC Form 13F

10 of the 45 institutional funds we track reported a RCUS position for the quarter ended 30 Jun 2026 — a combined $282.8M; the latest of those filings landed 14 Aug 2026.

Fund Action Shares Value
Citadel Advisors Added +135.7% shares 3,135,057 $96.7M
Fisher Asset Management Held (±25%) −2.3% shares 2,139,396 $66.0M
Marshall Wace Trimmed −48.3% shares 1,945,088 $60.0M
Baker Bros. Advisors Added +103.3% shares 844,816 $26.0M
Two Sigma Investments Added +103.2% shares 635,404 $19.6M
Man Group Added +70.4% shares 137,763 $4.2M
Millennium Management New position 133,110 $4.1M
D. E. Shaw & Co. Trimmed −62.8% shares 96,417 $3.0M
AQR Capital Management Held (±25%) −2.8% shares 83,861 $2.6M
Balyasny Asset Management New position 22,845 $704K

Source: SEC EDGAR 13F filings